Unlike LDL or triglycerides, Lp(a) is almost entirely determined by genetics. Lifestyle changes such as diet and exercise have little effect.
However, certain factors may slightly influence levels. Increased levels could be tied to kidney disease, inflammation or illness, growth hormone therapy, or hypothyroidism. Decreased levels could be associated with hyperthyroidism, liver disease, or certain Lp(a)-lowering medications currently under investigation (e.g., PCSK9 inhibitors, antisense therapies).
Individuals with Lp(a) less than 30 milligrams per deciliter (mg/dL) are considered at low risk; 30–50 mg/dL is intermediate risk; greater than 50 mg/dL is elevated risk.
Some at-home kits may include Lp(a) testing, but availability is limited. Most reliable testing is done in labs.
No. Unlike standard cholesterol tests, fasting is not required.
Usually once. Because levels are genetically determined, repeat testing is not often necessary unless your provider needs to confirm results or evaluate changes in risk.
Elevated Lp(a) is associated with heart disease, including heart attack, stroke, and other cardiovascular conditions.
Currently, no widely available drugs specifically target Lp(a). Some therapies in development show promise. For now, treatment focuses on lowering LDL and managing overall risk.